4DX logo

4DMedical Stock Price

Symbol: ASX:4DXMarket Cap: AU$197.9mCategory: Healthcare

4DX Share Price Performance

AU$0.42
-0.02 (-4.49%)
41.4% undervalued intrinsic discount
AU$0.72
Fair Value
AU$0.42
-0.02 (-4.49%)
41.4% undervalued intrinsic discount
AU$0.72
Fair Value
Price AU$0.42
AnalystConsensusTarget AU$0.72

4DX Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value AU$0.72 41.4% undervalued intrinsic discount

Acquisitions, Philips Partnerships And FDA Approvals Will Expand Market Reach

0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative

Recent 4DX News & Updates

No updates

4DMedical Limited Key Details

AU$5.9m

Revenue

AU$374.6k

Cost of Revenue

AU$5.5m

Gross Profit

AU$45.0m

Other Expenses

-AU$39.5m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.085
Gross Margin
93.60%
Net Profit Margin
-675.09%
Debt/Equity Ratio
0%

4DMedical Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About 4DX

Founded
2012
Employees
145
CEO
Andreas Fouras
WebsiteView website
4dmedical.com

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations. The company was incorporated in 2012 and is based in Carlton, Australia.

Australian Market Performance

  • 7 Days: 1.8%
  • 3 Months: 7.4%
  • 1 Year: 13.1%
  • Year to Date: 7.0%
The market has climbed 1.8% in the last 7 days, lead by the Materials sector with a gain of 5.6%. In the last year, the market has climbed 13%. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading